Irvine, Calif. - Sweat has a new enemy. Botox (botulinum toxin type A), developed by Allergan, has been approved by the U.S. Food and Drug Administration (FDA) to treat hyperhidrosis.
Study Reports High Frequency of Emergency Complications During Dermatological, Surgical, and Cosmetic Procedures
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Exploring the Intersection of Permanent Makeup and Dermatology
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Facial Redness Reduction Cosmetics
Hands-on Workshop Empowers Clinicians in Cosmetic Dermatology